In the same week that Eli Lilly filed three lawsuits against online vendors and wellness spas making compounded versions of tirzepatide, Novo Nordisk has asked the US Food and Drug Administration (FDA ...
Eli Lilly has sued three more companies that claim to be selling versions of tirzepatide, the main ingredient in the drugmaker’s weight loss treatment Zepbound … ...
The new lawsuits, which name Pivotal Peptides, MangoRx and Genesis Lifestyle Medicine of Nevada, are the first related to copycat tirzepatide filed since the U.S. Food and Drug Administration took ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback